1 Buprenorphine Transdermal Patches Market Overview 1.1 Product Overview and Scope of Buprenorphine Transdermal Patches 1.2 Buprenorphine Transdermal Patches Segment by Type 1.2.1 Global Buprenorphine Transdermal Patches Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 5mcg/h 1.2.3 7.5mcg/h 1.2.4 10mcg/h 1.2.5 15 mcg/h 1.2.6 20 mcg/h 1.3 Buprenorphine Transdermal Patches Segment by Application 1.3.1 Global Buprenorphine Transdermal Patches Sales Comparison by Application: (2021-2027) 1.3.2 Relieve Cancer Pain 1.3.3 Other 1.4 Global Buprenorphine Transdermal Patches Market Size Estimates and Forecasts 1.4.1 Global Buprenorphine Transdermal Patches Revenue 2016-2027 1.4.2 Global Buprenorphine Transdermal Patches Sales 2016-2027 1.4.3 Buprenorphine Transdermal Patches Market Size by Region: 2016 Versus 2021 Versus 2027 2 Buprenorphine Transdermal Patches Market Competition by Manufacturers 2.1 Global Buprenorphine Transdermal Patches Sales Market Share by Manufacturers (2016-2021) 2.2 Global Buprenorphine Transdermal Patches Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Buprenorphine Transdermal Patches Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Buprenorphine Transdermal Patches Manufacturing Sites, Area Served, Product Type 2.5 Buprenorphine Transdermal Patches Market Competitive Situation and Trends 2.5.1 Buprenorphine Transdermal Patches Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Buprenorphine Transdermal Patches Players Market Share by Revenue 2.5.3 Global Buprenorphine Transdermal Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Buprenorphine Transdermal Patches Retrospective Market Scenario by Region 3.1 Global Buprenorphine Transdermal Patches Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Buprenorphine Transdermal Patches Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Buprenorphine Transdermal Patches Market Facts & Figures by Country 3.3.1 North America Buprenorphine Transdermal Patches Sales by Country 3.3.2 North America Buprenorphine Transdermal Patches Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Buprenorphine Transdermal Patches Market Facts & Figures by Country 3.4.1 Europe Buprenorphine Transdermal Patches Sales by Country 3.4.2 Europe Buprenorphine Transdermal Patches Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Buprenorphine Transdermal Patches Market Facts & Figures by Region 3.5.1 Asia Pacific Buprenorphine Transdermal Patches Sales by Region 3.5.2 Asia Pacific Buprenorphine Transdermal Patches Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Buprenorphine Transdermal Patches Market Facts & Figures by Country 3.6.1 Latin America Buprenorphine Transdermal Patches Sales by Country 3.6.2 Latin America Buprenorphine Transdermal Patches Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Buprenorphine Transdermal Patches Market Facts & Figures by Country 3.7.1 Middle East and Africa Buprenorphine Transdermal Patches Sales by Country 3.7.2 Middle East and Africa Buprenorphine Transdermal Patches Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Buprenorphine Transdermal Patches Historic Market Analysis by Type 4.1 Global Buprenorphine Transdermal Patches Sales Market Share by Type (2016-2021) 4.2 Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2016-2021) 4.3 Global Buprenorphine Transdermal Patches Price by Type (2016-2021) 5 Global Buprenorphine Transdermal Patches Historic Market Analysis by Application 5.1 Global Buprenorphine Transdermal Patches Sales Market Share by Application (2016-2021) 5.2 Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2016-2021) 5.3 Global Buprenorphine Transdermal Patches Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Grunenthal 6.1.1 Grunenthal Corporation Information 6.1.2 Grunenthal Description and Business Overview 6.1.3 Grunenthal Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Grunenthal Buprenorphine Transdermal Patches Product Portfolio 6.1.5 Grunenthal Recent Developments/Updates 6.2 PurduePharma 6.2.1 PurduePharma Corporation Information 6.2.2 PurduePharma Description and Business Overview 6.2.3 PurduePharma Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2016-2021) 6.2.4 PurduePharma Buprenorphine Transdermal Patches Product Portfolio 6.2.5 PurduePharma Recent Developments/Updates 6.3 Luye Pharma 6.3.1 Luye Pharma Corporation Information 6.3.2 Luye Pharma Description and Business Overview 6.3.3 Luye Pharma Buprenorphine Transdermal Patches Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Luye Pharma Buprenorphine Transdermal Patches Product Portfolio 6.3.5 Luye Pharma Recent Developments/Updates 7 Buprenorphine Transdermal Patches Manufacturing Cost Analysis 7.1 Buprenorphine Transdermal Patches Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Buprenorphine Transdermal Patches 7.4 Buprenorphine Transdermal Patches Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Buprenorphine Transdermal Patches Distributors List 8.3 Buprenorphine Transdermal Patches Customers 9 Buprenorphine Transdermal Patches Market Dynamics 9.1 Buprenorphine Transdermal Patches Industry Trends 9.2 Buprenorphine Transdermal Patches Growth Drivers 9.3 Buprenorphine Transdermal Patches Market Challenges 9.4 Buprenorphine Transdermal Patches Market Restraints 10 Global Market Forecast 10.1 Buprenorphine Transdermal Patches Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Buprenorphine Transdermal Patches by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Buprenorphine Transdermal Patches by Type (2022-2027) 10.2 Buprenorphine Transdermal Patches Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Buprenorphine Transdermal Patches by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Buprenorphine Transdermal Patches by Application (2022-2027) 10.3 Buprenorphine Transdermal Patches Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Buprenorphine Transdermal Patches by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Buprenorphine Transdermal Patches by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Buprenorphine Transdermal Patches Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Buprenorphine Transdermal Patches Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Buprenorphine Transdermal Patches Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Buprenorphine Transdermal Patches Covered in This Study Table 5. Global Buprenorphine Transdermal Patches Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Buprenorphine Transdermal Patches Sales Market Share by Manufacturers (2016-2021) Table 7. Global Buprenorphine Transdermal Patches Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Buprenorphine Transdermal Patches Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Buprenorphine Transdermal Patches Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Buprenorphine Transdermal Patches Manufacturing Sites and Area Served Table 11. Manufacturers Buprenorphine Transdermal Patches Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Buprenorphine Transdermal Patches by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Buprenorphine Transdermal Patches as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Buprenorphine Transdermal Patches Sales by Region (2016-2021) & (K Units) Table 16. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2016-2021) Table 17. Global Buprenorphine Transdermal Patches Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Buprenorphine Transdermal Patches Sales by Country (2016-2021) & (K Units) Table 19. North America Buprenorphine Transdermal Patches Sales Market Share by Country (2016-2021) Table 20. North America Buprenorphine Transdermal Patches Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Buprenorphine Transdermal Patches Revenue Market Share by Country (2016-2021) Table 22. Europe Buprenorphine Transdermal Patches Sales by Country (2016-2021) & (K Units) Table 23. Europe Buprenorphine Transdermal Patches Sales Market Share by Country (2016-2021) Table 24. Europe Buprenorphine Transdermal Patches Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Buprenorphine Transdermal Patches Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Buprenorphine Transdermal Patches Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Buprenorphine Transdermal Patches Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Buprenorphine Transdermal Patches Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Buprenorphine Transdermal Patches Revenue Market Share by Region (2016-2021) Table 30. Latin America Buprenorphine Transdermal Patches Sales by Country (2016-2021) & (K Units) Table 31. Latin America Buprenorphine Transdermal Patches Sales Market Share by Country (2016-2021) Table 32. Latin America Buprenorphine Transdermal Patches Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Buprenorphine Transdermal Patches Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Buprenorphine Transdermal Patches Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Buprenorphine Transdermal Patches Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Buprenorphine Transdermal Patches Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Buprenorphine Transdermal Patches Revenue Market Share by Country (2016-2021) Table 38. Global Buprenorphine Transdermal Patches Sales (K Units) by Type (2016-2021) Table 39. Global Buprenorphine Transdermal Patches Sales Market Share by Type (2016-2021) Table 40. Global Buprenorphine Transdermal Patches Revenue (Million US$) by Type (2016-2021) Table 41. Global Buprenorphine Transdermal Patches Revenue Share by Type (2016-2021) Table 42. Global Buprenorphine Transdermal Patches Price (US$/Unit) by Type (2016-2021) Table 43. Global Buprenorphine Transdermal Patches Sales (K Units) by Application (2016-2021) Table 44. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2016-2021) Table 45. Global Buprenorphine Transdermal Patches Revenue (Million US$) by Application (2016-2021) Table 46. Global Buprenorphine Transdermal Patches Revenue Share by Application (2016-2021) Table 47. Global Buprenorphine Transdermal Patches Price (US$/Unit) by Application (2016-2021) Table 48. Grunenthal Corporation Information Table 49. Grunenthal Description and Business Overview Table 50. Grunenthal Buprenorphine Transdermal Patches Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. Grunenthal Buprenorphine Transdermal Patches Product Table 52. Grunenthal Recent Developments/Updates Table 53. PurduePharma Corporation Information Table 54. PurduePharma Description and Business Overview Table 55. PurduePharma Buprenorphine Transdermal Patches Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. PurduePharma Buprenorphine Transdermal Patches Product Table 57. PurduePharma Recent Developments/Updates Table 58. Luye Pharma Corporation Information Table 59. Luye Pharma Description and Business Overview Table 60. Luye Pharma Buprenorphine Transdermal Patches Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. Luye Pharma Buprenorphine Transdermal Patches Product Table 62. Luye Pharma Recent Developments/Updates Table 63. Production Base and Market Concentration Rate of Raw Material Table 64. Key Suppliers of Raw Materials Table 65. Buprenorphine Transdermal Patches Distributors List Table 66. Buprenorphine Transdermal Patches Customers List Table 67. Buprenorphine Transdermal Patches Market Trends Table 68. Buprenorphine Transdermal Patches Growth Drivers Table 69. Buprenorphine Transdermal Patches Market Challenges Table 70. Buprenorphine Transdermal Patches Market Restraints Table 71. Global Buprenorphine Transdermal Patches Sales Forecast by Type (2022-2027) & (K Units) Table 72. Global Buprenorphine Transdermal Patches Sales Market Share Forecast by Type (2022-2027) Table 73. Global Buprenorphine Transdermal Patches Revenue Forecast by Type (2022-2027) & (US$ Million) Table 74. Global Buprenorphine Transdermal Patches Revenue Market Share Forecast by Type (2022-2027) Table 75. Global Buprenorphine Transdermal Patches Sales Forecast by Application (2022-2027) & (K Units) Table 76. Global Buprenorphine Transdermal Patches Sales Market Share Forecast by Application (2022-2027) Table 77. Global Buprenorphine Transdermal Patches Revenue Forecast by Application (2022-2027) & (US$ Million) Table 78. Global Buprenorphine Transdermal Patches Revenue Market Share Forecast by Application (2022-2027) Table 79. Global Buprenorphine Transdermal Patches Sales Forecast by Region (2022-2027) & (K Units) Table 80. Global Buprenorphine Transdermal Patches Sales Market Share Forecast by Region (2022-2027) Table 81. Global Buprenorphine Transdermal Patches Revenue Forecast by Region (2022-2027) & (US$ Million) Table 82. Global Buprenorphine Transdermal Patches Revenue Market Share Forecast by Region (2022-2027) Table 83. Research Programs/Design for This Report Table 84. Key Data Information from Secondary Sources Table 85. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Buprenorphine Transdermal Patches Figure 2. Global Buprenorphine Transdermal Patches Market Share by Type in 2020 & 2027 Figure 3. 5mcg/h Product Picture Figure 4. 7.5mcg/h Product Picture Figure 5. 10mcg/h Product Picture Figure 6. 15 mcg/h Product Picture Figure 7. 20 mcg/h Product Picture Figure 8. Global Buprenorphine Transdermal Patches Market Share by Application in 2020 & 2027 Figure 9. Relieve Cancer Pain Figure 10. Other Figure 11. Global Buprenorphine Transdermal Patches Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Buprenorphine Transdermal Patches Market Size 2016-2027 (US$ Million) Figure 13. Global Buprenorphine Transdermal Patches Sales 2016-2027 (K Units) Figure 14. Global Buprenorphine Transdermal Patches Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Buprenorphine Transdermal Patches Sales Share by Manufacturers in 2020 Figure 16. Global Buprenorphine Transdermal Patches Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Buprenorphine Transdermal Patches Players: Market Share by Revenue in 2020 Figure 18. Buprenorphine Transdermal Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2016-2021) Figure 20. Global Buprenorphine Transdermal Patches Sales Market Share by Region in 2020 Figure 21. Global Buprenorphine Transdermal Patches Revenue Market Share by Region (2016-2021) Figure 22. Global Buprenorphine Transdermal Patches Revenue Market Share by Region in 2020 Figure 23. U.S. Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. U.K. Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Taiwan Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Philippines Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Vietnam Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Mexico Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Brazil Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Argentina Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Turkey Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Saudi Arabia Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. UAE Buprenorphine Transdermal Patches Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Sales Market Share of Buprenorphine Transdermal Patches by Type (2016-2021) Figure 48. Sales Market Share of Buprenorphine Transdermal Patches by Application (2016-2021) Figure 49. Sales Market Share of Buprenorphine Transdermal Patches by Application in 2020 Figure 50. Revenue Share of Buprenorphine Transdermal Patches by Application (2016-2021) Figure 51. Revenue Share of Buprenorphine Transdermal Patches by Application in 2020 Figure 52. Manufacturing Cost Structure of Buprenorphine Transdermal Patches Figure 53. Manufacturing Process Analysis of Buprenorphine Transdermal Patches Figure 54. Buprenorphine Transdermal Patches Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Grunenthal PurduePharma Luye Pharma